Literature DB >> 17244336

Histopathological study of time course changes in inter-renal aortic banding-induced left ventricular hypertrophy of mice.

Hiroyuki Higashiyama1, Masaki Sugai, Hirotaka Inoue, Kaori Mizuyachi, Hiroshi Kushida, Satoshi Asano, Mine Kinoshita.   

Abstract

The left ventricular hypertrophy (LVH) in response to pressure overload is an important risk factor in cardiac morbidity and mortality. To investigate the time course of histopathological alterations in the LVH in response to pressure overload, histopathological and immunohistochemical examination was performed using the aortic banding-induced mouse LVH model. Five-week-old male CD-1 mice were subjected to the inter-renal aortic banding. Major organs were sampled on 3, 10, 14, 21, 28 or 42 days after banding. Haematoxylin and eosin (H&E) staining, Masson's trichrome staining and immunohistochemistry for proliferating cell nuclear antigen (PCNA), alpha-smooth muscle actin (aSMA), ICAM-1, type I collagen and CD31 was performed and microscopically examined. Three days after aortic banding, acute inflammatory changes, such as macrophages/neutrophil infiltration and vascular wall injury were observed on/around the coronary arteries/arterioles of both ventricles. Intense ICAM-1 immunostaining was observed on the endothelium of the coronary arteries/arterioles. After day 10, vascular wall thickening and perivascular fibrosis was induced on the coronary arteries/arterioles. Immunohistochemistry for aSMA and PCNA demonstrated the proliferation of vascular smooth muscle cells in the media. After day 28, minimal cardiomyocyte hypertrophy was observed at the light microscope level. In the inter-renal aortic banding LVH model, histopathological alterations in early phase were mainly observed on coronary arteries/arterioles. These early phase alterations were thought to be hypertension-related changes in the coronary vasculatures. The cardiomyocyte hypertrophy observed in later phase was minimal at the light microscope level. These evidences would facilitate the understanding of pathophysiology of pressure overload LVH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244336      PMCID: PMC2517284          DOI: 10.1111/j.1365-2613.2006.00514.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  27 in total

Review 1.  Cardiac remodeling and failure: from molecules to man (Part I).

Authors:  Paul W M Fedak; Subodh Verma; Richard D Weisel; Ren-Ke Li
Journal:  Cardiovasc Pathol       Date:  2005 Jan-Feb       Impact factor: 2.185

2.  Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure.

Authors:  Marc Brede; Frank Wiesmann; Roland Jahns; Kerstin Hadamek; Carsten Arnolt; Stefan Neubauer; Martin J Lohse; Lutz Hein
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

3.  Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling.

Authors:  Fumitaka Kuwahara; Hisashi Kai; Keisuke Tokuda; Hiroshi Niiyama; Nobuhiro Tahara; Ken Kusaba; Kiyoko Takemiya; Ali Jalalidin; Mitsuhisa Koga; Tsuyoshi Nagata; Rei Shibata; Tsutomu Imaizumi
Journal:  Hypertension       Date:  2003-02-03       Impact factor: 10.190

4.  Inhibition of tumor necrosis factor-alpha improves postischemic recovery of hypertrophied hearts.

Authors:  C Stamm; I Friehs; D B Cowan; A M Moran; H Cao-Danh; L F Duebener; P J del Nido; F X McGowan
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

5.  Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. A quantitative autoradiographic study.

Authors:  Y Kagaya; Y Kanno; D Takeyama; N Ishide; Y Maruyama; T Takahashi; T Ido; T Takishima
Journal:  Circulation       Date:  1990-04       Impact factor: 29.690

6.  Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.

Authors:  Giovanni Esposito; Antonio Rapacciuolo; Sathyamangla V Naga Prasad; Hideyuki Takaoka; Steven A Thomas; Walter J Koch; Howard A Rockman
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

7.  Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats.

Authors:  K M Baker; M I Chernin; S K Wixson; J F Aceto
Journal:  Am J Physiol       Date:  1990-08

8.  Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats.

Authors:  Fumitaka Kuwahara; Hisashi Kai; Keisuke Tokuda; Mamiko Kai; Akira Takeshita; Kensuke Egashira; Tsutomu Imaizumi
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

9.  Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study.

Authors:  D Levy; K M Anderson; D D Savage; S A Balkus; W B Kannel; W P Castelli
Journal:  Am J Cardiol       Date:  1987-09-01       Impact factor: 2.778

10.  Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  Ann Intern Med       Date:  1989-01-15       Impact factor: 25.391

View more
  4 in total

1.  Partial nephrectomy as a model for uremic cardiomyopathy in the mouse.

Authors:  David J Kennedy; Jihad Elkareh; Amjad Shidyak; Anna P Shapiro; Sleiman Smaili; Krishna Mutgi; Shalini Gupta; Jiang Tian; Eric Morgan; Samer Khouri; Christopher J Cooper; Sankaridrug M Periyasamy; Zijian Xie; Deepak Malhotra; Olga V Fedorova; Alexei Y Bagrov; Joseph I Shapiro
Journal:  Am J Physiol Renal Physiol       Date:  2007-11-21

2.  Bone marrow support of the heart in pressure overload is lost with aging.

Authors:  Nikolai A Sopko; Benjamin A Turturice; Mitchell E Becker; Chase R Brown; Feng Dong; Zoran B Popović; Marc S Penn
Journal:  PLoS One       Date:  2010-12-21       Impact factor: 3.240

3.  Peptidylarginine deiminase 4 promotes age-related organ fibrosis.

Authors:  Kimberly Martinod; Thilo Witsch; Luise Erpenbeck; Alexander Savchenko; Hideki Hayashi; Deya Cherpokova; Maureen Gallant; Maximilian Mauler; Stephen M Cifuni; Denisa D Wagner
Journal:  J Exp Med       Date:  2016-12-28       Impact factor: 14.307

4.  Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy.

Authors:  Shu-Huai Tsai; Guangrong Lu; Xin Xu; Yi Ren; Travis W Hein; Lih Kuo
Journal:  Cardiovasc Res       Date:  2017-09-01       Impact factor: 10.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.